Novel dietary compound enhances stroke therapy by targeting platelets
The study explores how sulforaphane (SFN), a compound found in broccoli, selectively inhibits platelet activity without increasing bleeding risks. SFN covalently modifies specific proteins in platelets, notably PDIA6, which affects platelet aggregation and enhances the efficacy of clot-busting therapies like rtPA in stroke treatment. This discovery suggests SFN’s potential as a novel prophylactic agent to improve stroke outcomes.
https://pubs.acs.org/doi/full/10.1021/acscentsci.3c00822
Broccoli compound shows promise in stroke treatment
Researchers have identified sulforaphane, a compound in broccoli, as a potential therapy to improve stroke treatment. This natural compound targets platelets, reducing blood clot formation without increasing bleeding risks, which could enhance the effectiveness of current stroke treatments like thrombolysis. The discovery suggests that sulforaphane could be a key ingredient in future strategies to prevent and treat strokes.
https://www.hriuk.org/news/common-veggie-could-be-secret-weapon-to-treat-stroke
Broccoli contains compounds like sulforaphane that have potent health benefits, including anti-cancer properties and protection against heart disease. These compounds support detoxification processes and can reduce inflammation. Science continues to uncover the incredible effects of broccoli on human health, reinforcing its status as a nutritional powerhouse.
Ils en parlent : https://www.numerama.com/sciences/1654378-le-brocoli-est-incroyable-la-science-explique-pourquoi.html
0 Comments